// App-Quantinova.ai

MON-1017 : Canagliflozin Associated Acute Renal Failure in a Patient with Stage II CKD and Compensated Heart Failure

Researchers

Presenter

  • Maria Javaid

Principal Investigators

  • Jennifer Giordano

  • Robert J Tanenberg

  • Hassan Alhosaini

  • Caroline M Houston

Medical Centers

  • East Carolina Univ, Winterville, NC

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Non-Ischemic cardiomyopathy

  • Type 2 diabetes mellitus

  • Ischemic cardiomyopathy

  • Chronic kidney disease

  • Diabetic retinopathy

  • Acute renal failure

  • Diabetes

  • Renal disease

  • Heart muscle disease

  • Congestive heart failure

  • Renal insufficiency

  • Obesity

Biomarkers

  • Acetyl-CoA carboxylase

  • Creatinine

  • Hemoglobin A1c

Drug/Treatment

  • Spironolactone

  • Canagliflozin

  • Bumetanide

  • Lisinopril

  • Cipril

  • Nebivolol

  • Digoxin

  • NovoLog

  • Insulin glargine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved